Stocktoria
Lunai Bioworks Inc. LNAI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-11-18
Lunai Bioworks Inc. statistics & valuation
Market cap$14.6M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -2162.7% | -54.2% | -68.1% | -134.0% | -14.1% |
| Return on equity | 833.8% | -67.0% | -85.3% | -156.2% | -15.3% |
| Current ratio | 0.04 | 0.07 | 0.23 | 1.48 | 11.08 |
Source: SEC EDGAR filings · CIK 0001527728 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.